ϟ
DOI: 10.1016/s0140-6736(21)00588-2
OpenAccess: Closed
This work is not Open Acccess. We may still have a PDF, if this is the case there will be a green box below.
Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials
Emma Guttman‐Yassky,Henrique D. Teixeira,Eric L. Simpson,Kim Papp,Aileen L. Pangan,Andrew Blauvelt,Diamant Thaçi,Chia Yu Chu,H. Chih ho Hong,Norito Katoh,Amy S. Paller,Brian Calimlim,Yihua Gu,Xiaofei Hu,Meng Li,Yang Yang,John Liu,Allan R. Tenorio,Alvina D. Chu,Alan D. Irvine
Eczema Area and Severity Index
Atopic dermatitis
Placebo
2021
Loading...
- MLA
- APA
- Chicago
- IEEE
- Harvard
- BibTeX
Cite this:
Generate Citation
“Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials” is a paper by Emma Guttman‐Yassky Henrique D. Teixeira Eric L. Simpson Kim Papp Aileen L. Pangan Andrew Blauvelt Diamant Thaçi Chia Yu Chu H. Chih ho Hong Norito Katoh Amy S. Paller Brian Calimlim Yihua Gu Xiaofei Hu Meng Li Yang Yang John Liu Allan R. Tenorio Alvina D. Chu Alan D. Irvine published in 2021. It has an Open Access status of “closed”. You can read and download a PDF Full Text of this paper here.